162 related articles for article (PubMed ID: 36208171)
21. Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant.
Chapman FA; Dickerson JE; Daly C; Clancy M; Geddes C
Ann Transplant; 2019 Dec; 24():625-630. PubMed ID: 31806862
[TBL] [Abstract][Full Text] [Related]
22. Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome.
Mihm LB; Rathbun RC; Resman-Targoff BH
Pharmacotherapy; 1995; 15(6):793-7. PubMed ID: 8602391
[TBL] [Abstract][Full Text] [Related]
23. Hyponatremia Associated With Standard-Dose Trimethoprim-Sulfamethoxazole Use in an Immunocompetent Patient.
Azeem A; Majeed N; Khuwaja S
WMJ; 2022 Oct; 121(3):E57-E59. PubMed ID: 36301661
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study.
Rajput J; Moore LSP; Mughal N; Hughes S
Clin Microbiol Infect; 2020 Dec; 26(12):1651-1657. PubMed ID: 32220637
[TBL] [Abstract][Full Text] [Related]
25. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?
Alappan R; Buller GK; Perazella MA
Am J Nephrol; 1999; 19(3):389-94. PubMed ID: 10393376
[TBL] [Abstract][Full Text] [Related]
26. Case report: reversible hyperkalemia associated with trimethoprim- sulfamethoxazole.
Marinella MA
Am J Med Sci; 1995 Sep; 310(3):115-7. PubMed ID: 7668307
[TBL] [Abstract][Full Text] [Related]
27. Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure.
Tsapepas D; Chiles M; Babayev R; Rao MK; Jaitly M; Salerno D; Mohan S
Am J Med; 2016 Dec; 129(12):1322-1328. PubMed ID: 27542610
[TBL] [Abstract][Full Text] [Related]
28. Trimethoprim-Sulfamethoxazole-associated early neutropenia in Mexican adults living with HIV: A cohort study.
Jacobo-Vargas TB; Báez-Saldaña R; Cruz-Hervert LP; Fortoul TI; Ahumada-Topete VH; Rodríguez-Ganén O; Vega-Barrientos RS
PLoS One; 2023; 18(5):e0285541. PubMed ID: 37167312
[TBL] [Abstract][Full Text] [Related]
29. Trimethoprim-Sulfamethoxazole for Pediatric Osteoarticular Infections.
McDaniel LM; Fiawoo S; Tamma PD; Same RG
J Pediatric Infect Dis Soc; 2023 Oct; 12(10):534-539. PubMed ID: 37757866
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of risk factors for acute kidney injury among inpatients administered sulfamethoxazole/trimethoprim: a retrospective observational study.
Shimizu Y; Hirai T; Ogawa Y; Yamada C; Kobayashi E
J Pharm Health Care Sci; 2022 Aug; 8(1):20. PubMed ID: 35909129
[TBL] [Abstract][Full Text] [Related]
31. Hyponatremia after initiation and rechallenge with trimethoprim-sulfamethoxazole in an older adult.
Huntsberry AM; Linnebur SA; Vejar M
Clin Interv Aging; 2015; 10():1091-6. PubMed ID: 26170649
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
[TBL] [Abstract][Full Text] [Related]
33. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone.
Antoniou T; Hollands S; Macdonald EM; Gomes T; Mamdani MM; Juurlink DN;
CMAJ; 2015 Mar; 187(4):E138-E143. PubMed ID: 25646289
[TBL] [Abstract][Full Text] [Related]
34. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
35. Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study.
Mendel A; Behlouli H; de Moura CS; Vinet É; Curtis JR; Bernatsky S
Arthritis Res Ther; 2023 Jul; 25(1):133. PubMed ID: 37516897
[TBL] [Abstract][Full Text] [Related]
36. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
[TBL] [Abstract][Full Text] [Related]
37. Trimethoprim-sulfamethoxazole-induced hyponatremia.
Dunn RL; Smith WJ; Stratton MA
Consult Pharm; 2011 May; 26(5):342-9. PubMed ID: 21733815
[TBL] [Abstract][Full Text] [Related]
38. Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study.
Creemers-Schild D; Kroon FP; Kuijper EJ; de Boer MG
Infection; 2016 Jun; 44(3):291-9. PubMed ID: 26471512
[TBL] [Abstract][Full Text] [Related]
39. Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Raz-Pasteur A; Liron Y; Amir-Ronen R; Abdelgani S; Ohanyan A; Geffen Y; Paul M
J Glob Antimicrob Resist; 2019 Jun; 17():168-172. PubMed ID: 30557685
[TBL] [Abstract][Full Text] [Related]
40. Is trimethoprim/sulfamethoxazole-associated increase in serum creatinine a pseudo-elevation or true nephrotoxicity?
Urakami T; Hamada Y; Oka Y; Kannae M; Okinaka T; Sanada A; Shimanoe C; Aoki Y
J Infect Chemother; 2021 Aug; 27(8):1193-1197. PubMed ID: 33832848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
